Search results
401 results found
No one left behind: equity in the age of digital healthBlogIn a society that spans multiple generations with vastly differing levels of digital literacy and access to resources, one question looms large: who benefits from the digital health transformation, and who risks being left behind?
AI-driven multiomics: a vision for personalised medicineLong-readIn a society that spans multiple generations with vastly differing levels of digital literacy and access to resources, one question looms large: who benefits from the digital health transformation, and who risks being left behind?
Expanding testing of cancer susceptibility genes from the clinic to the population: exploring the evidence gapsPast event
The polygenic score paradox: navigating the hope, hype, and hurdles BlogThe successes of polygenic score research are not trivial; they represent real progress and are the reason why researchers, clinicians, and even commercial companies are forging ahead. And yet, for every promising headline, a wave of cautionary evidence is building, urging a more measured and critical perspective.
Early results from the CYP2C19 genotype testing pilot – a landmark moment for personalised stroke careBlogIn a society that spans multiple generations with vastly differing levels of digital literacy and access to resources, one question looms large: who benefits from the digital health transformation, and who risks being left behind?
Holding the line: why host genomics (and infectious disease) research matters more than everBlogOne year ago, the PHG Foundation report, Host genomics: lessons for infectious diseases, highlighted the promise of host genomics research for infectious disease. Policy priorities may have changed since then, the evidence has not.
Quantum computing: The future of healthcare in the UK?Long-readQuantum computing, a type of quantum technology, is poised to address pressing challenges in the healthcare sector. Quantum-based discovery techniques could augment and accelerate existing efforts in drug discovery, diagnostics and precision medicine.
How can genomics inform the public health response to the threat of meningococcal disease?BlogNational attention has been gripped by the recent meningitis outbreak.
What the UK Biobank data exposure should mean for the Health Data Research ServiceBlogPotential fallout from the recent UK Biobank data exposure - and similar cases - highlights that governance cannot be treated as an administrative add on.